Form 4 for ALLR Allarity Therapeutics, Inc.
Accepted 2026-05-11 15:21:46 ET · period of report 2026-01-28 · accession 0001213900-26-054430 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 15:21 | 2026-01-07 | ALLR | Hoeiland Jesper | Dir | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-07 | A | A | 25,000 | $0.00 | 25,000 | D | — | — | (F1) The restricted stock units, or RSUs, granted on January 28, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, vested in full on the grant date. |